Status:
COMPLETED
Intraoperative Aromatherapy Versus Placebo for Port-a-Cath Placement Under Monitored Anesthesia Care. A Randomized Controlled Trial
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Cancer Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This is a prospective, controlled, randomized trial. Primary objective is to compare the time to readiness for discharge (minutes) from Post-Anesthesia Care Unit (PACU) after Port-a-Cath placement sur...
Detailed Description
Primary Objective: To compare the time to readiness for discharge (minutes) from Post-Anesthesia Care Unit (PACU) after Port-a-Cath placement surgery between patients who are randomized to receive in...
Eligibility Criteria
Inclusion
- Adult patients (≥ 18 years old)
- Port-a-Cath placement under Monitored Anesthesia Care
- Signed informed consent
Exclusion
- Patients undergoing other surgical procedures during Port-a-Cath placement (including explantation of a Port-a-Cath or other previous vascular access device)
- Patients requiring general anesthesia or those not eligible for MAC
Key Trial Info
Start Date :
May 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 16 2024
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05328973
Start Date
May 18 2022
End Date
January 16 2024
Last Update
December 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MD Anderson Cancer Center
Houston, Texas, United States, 77030